There were 521 press releases posted in the last 24 hours and 166,626 in the last 365 days.

Global Melanoma Therapeutics Industry

Melanoma Therapeutics market worldwide is projected to grow by US$3. 9 Billion, driven by a compounded growth of 12. 4%. Cutaneous Melanoma, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Melanoma Therapeutics Industry" - https://www.reportlinker.com/p05818007/?utm_source=GNW
2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Cutaneous Melanoma will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.5 Million to the region’s size and clout in the next 5 to 6 years. Over US$127.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cutaneous Melanoma will reach a market size of US$158.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 15.8% over the next couple of years and add approximately US$924 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eisai Co., Ltd.; F. Hoffmann-La Roche AG; Iovance Biotherapeutics, Inc.; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p05818007/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Melanoma Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Melanoma Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Melanoma Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Melanoma Therapeutics Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Cutaneous Melanoma (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Cutaneous Melanoma (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Cutaneous Melanoma (Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Ocular Melanoma (Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Ocular Melanoma (Type) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Ocular Melanoma (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Mucosal Melanoma (Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Mucosal Melanoma (Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Mucosal Melanoma (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Surgery (Therapy) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Surgery (Therapy) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Surgery (Therapy) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Immunotherapy (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Immunotherapy (Therapy) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Immunotherapy (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Targeted Therapy (Therapy) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Targeted Therapy (Therapy) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Targeted Therapy (Therapy) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Chemotherapy (Therapy) Market Opportunity Analysis
Worldwide in US$ Million by Region/Country: 2018 to 2025
Table 23: Chemotherapy (Therapy) Global Historic Demand in US$
Million by Region/Country: 2009 to 2017
Table 24: Chemotherapy (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Radiation Therapy (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Radiation Therapy (Therapy) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 27: Radiation Therapy (Therapy) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Melanoma Therapeutics Market Share (in %) by Company: 2019 &
2025
Table 28: United States Melanoma Therapeutics Market Estimates
and Projections in US$ Million by Type: 2018 to 2025
Table 29: Melanoma Therapeutics Market in the United States by
Type: A Historic Review in US$ Million for 2009-2017
Table 30: United States Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 31: United States Melanoma Therapeutics Market Estimates
and Projections in US$ Million by Therapy: 2018 to 2025
Table 32: Melanoma Therapeutics Market in the United States by
Therapy: A Historic Review in US$ Million for 2009-2017
Table 33: United States Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
CANADA
Table 34: Canadian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 35: Canadian Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 36: Melanoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 37: Canadian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 38: Canadian Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 39: Melanoma Therapeutics Market in Canada: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
JAPAN
Table 40: Japanese Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 41: Melanoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Type for the Period 2009-2017
Table 42: Japanese Melanoma Therapeutics Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 43: Japanese Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 44: Melanoma Therapeutics Market in Japan: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 45: Japanese Melanoma Therapeutics Market Share Analysis
by Therapy: 2009 VS 2019 VS 2025
CHINA
Table 46: Chinese Melanoma Therapeutics Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 47: Melanoma Therapeutics Historic Market Analysis in
China in US$ Million by Type: 2009-2017
Table 48: Chinese Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 49: Chinese Melanoma Therapeutics Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 50: Melanoma Therapeutics Historic Market Analysis in
China in US$ Million by Therapy: 2009-2017
Table 51: Chinese Melanoma Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Melanoma Therapeutics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 52: European Melanoma Therapeutics Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 53: Melanoma Therapeutics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 54: European Melanoma Therapeutics Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 55: European Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 56: Melanoma Therapeutics Market in Europe in US$ Million
by Type: A Historic Review for the Period 2009-2017
Table 57: European Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 58: European Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 59: Melanoma Therapeutics Market in Europe in US$ Million
by Therapy: A Historic Review for the Period 2009-2017
Table 60: European Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 61: Melanoma Therapeutics Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 62: French Melanoma Therapeutics Historic Market Scenario
in US$ Million by Type: 2009-2017
Table 63: French Melanoma Therapeutics Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 64: Melanoma Therapeutics Market in France by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 65: French Melanoma Therapeutics Historic Market Scenario
in US$ Million by Therapy: 2009-2017
Table 66: French Melanoma Therapeutics Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 67: Melanoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 68: German Melanoma Therapeutics Historic Market Analysis
in US$ Million by Type: 2009-2017
Table 69: German Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 70: Melanoma Therapeutics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 71: German Melanoma Therapeutics Historic Market Analysis
in US$ Million by Therapy: 2009-2017
Table 72: German Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
ITALY
Table 73: Italian Melanoma Therapeutics Market Growth Prospects
in US$ Million by Type for the Period 2018-2025
Table 74: Melanoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Type: 2009-2017
Table 75: Italian Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 76: Italian Melanoma Therapeutics Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 77: Melanoma Therapeutics Historic Market Analysis in
Italy in US$ Million by Therapy: 2009-2017
Table 78: Italian Melanoma Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 79: United Kingdom Market for Melanoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2018-2025
Table 80: Melanoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2009-2017
Table 81: United Kingdom Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 82: United Kingdom Market for Melanoma Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Therapy for the Period 2018-2025
Table 83: Melanoma Therapeutics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapy for the
Period 2009-2017
Table 84: United Kingdom Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 85: Spanish Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 86: Spanish Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 87: Melanoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 88: Spanish Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 89: Spanish Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 90: Melanoma Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 91: Russian Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 92: Melanoma Therapeutics Market in Russia by Type: A
Historic Review in US$ Million for 2009-2017
Table 93: Russian Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 94: Russian Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 95: Melanoma Therapeutics Market in Russia by Therapy: A
Historic Review in US$ Million for 2009-2017
Table 96: Russian Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 97: Rest of Europe Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 98: Melanoma Therapeutics Market in Rest of Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 99: Rest of Europe Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 100: Rest of Europe Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Therapy: 2018-2025
Table 101: Melanoma Therapeutics Market in Rest of Europe in
US$ Million by Therapy: A Historic Review for the Period
2009-2017
Table 102: Rest of Europe Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 103: Asia-Pacific Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 104: Melanoma Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 105: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 106: Melanoma Therapeutics Market in Asia-Pacific by
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 107: Asia-Pacific Melanoma Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 108: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 109: Melanoma Therapeutics Market in Asia-Pacific by
Therapy: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 110: Asia-Pacific Melanoma Therapeutics Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 111: Asia-Pacific Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 112: Melanoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 113: Australian Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 114: Australian Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 115: Melanoma Therapeutics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 116: Australian Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 117: Australian Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
INDIA
Table 118: Indian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 119: Indian Melanoma Therapeutics Historic Market Review
by Type in US$ Million: 2009-2017
Table 120: Melanoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Type for 2009, 2019, and 2025
Table 121: Indian Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 122: Indian Melanoma Therapeutics Historic Market Review
by Therapy in US$ Million: 2009-2017
Table 123: Melanoma Therapeutics Market in India: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
SOUTH KOREA
Table 124: Melanoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2018-2025
Table 125: South Korean Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 126: Melanoma Therapeutics Market Share Distribution in
South Korea by Type: 2009 VS 2019 VS 2025
Table 127: Melanoma Therapeutics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 128: South Korean Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 129: Melanoma Therapeutics Market Share Distribution in
South Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Market for Melanoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 131: Melanoma Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Type
for the Period 2009-2017
Table 132: Rest of Asia-Pacific Melanoma Therapeutics Market
Share Analysis by Type: 2009 VS 2019 VS 2025
Table 133: Rest of Asia-Pacific Market for Melanoma
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Therapy for the Period 2018-2025
Table 134: Melanoma Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy
for the Period 2009-2017
Table 135: Rest of Asia-Pacific Melanoma Therapeutics Market
Share Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 136: Latin American Melanoma Therapeutics Market Trends
by Region/Country in US$ Million: 2018-2025
Table 137: Melanoma Therapeutics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 138: Latin American Melanoma Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 139: Latin American Melanoma Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 140: Melanoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Type: 2009-2017
Table 141: Latin American Melanoma Therapeutics Market by
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 142: Latin American Melanoma Therapeutics Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 143: Melanoma Therapeutics Historic Market Analysis in
Latin America in US$ Million by Therapy: 2009-2017
Table 144: Latin American Melanoma Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 145: Argentinean Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 146: Melanoma Therapeutics Market in Argentina in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 147: Argentinean Melanoma Therapeutics Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 148: Argentinean Melanoma Therapeutics Market Estimates
and Forecasts in US$ Million by Therapy: 2018-2025
Table 149: Melanoma Therapeutics Market in Argentina in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 150: Argentinean Melanoma Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 151: Melanoma Therapeutics Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 152: Brazilian Melanoma Therapeutics Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 153: Brazilian Melanoma Therapeutics Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 154: Melanoma Therapeutics Market in Brazil by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 155: Brazilian Melanoma Therapeutics Historic Market
Scenario in US$ Million by Therapy: 2009-2017
Table 156: Brazilian Melanoma Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 157: Melanoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 158: Mexican Melanoma Therapeutics Historic Market
Analysis in US$ Million by Type: 2009-2017
Table 159: Mexican Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 160: Melanoma Therapeutics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 161: Mexican Melanoma Therapeutics Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 162: Mexican Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 163: Rest of Latin America Melanoma Therapeutics Market
Estimates and Projections in US$ Million by Type: 2018 to 2025
Table 164: Melanoma Therapeutics Market in Rest of Latin
America by Type: A Historic Review in US$ Million for 2009-2017
Table 165: Rest of Latin America Melanoma Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 166: Rest of Latin America Melanoma Therapeutics Market
Estimates and Projections in US$ Million by Therapy: 2018 to
2025
Table 167: Melanoma Therapeutics Market in Rest of Latin
America by Therapy: A Historic Review in US$ Million for
2009-2017
Table 168: Rest of Latin America Melanoma Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 169: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 170: Melanoma Therapeutics Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 171: The Middle East Melanoma Therapeutics Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 172: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Table 173: The Middle East Melanoma Therapeutics Historic
Market by Type in US$ Million: 2009-2017
Table 174: Melanoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2009, 2019,
and 2025
Table 175: The Middle East Melanoma Therapeutics Market
Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
Table 176: The Middle East Melanoma Therapeutics Historic
Market by Therapy in US$ Million: 2009-2017
Table 177: Melanoma Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
IRAN
Table 178: Iranian Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2018-2025
Table 179: Melanoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Type for the Period 2009-2017
Table 180: Iranian Melanoma Therapeutics Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 181: Iranian Market for Melanoma Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 182: Melanoma Therapeutics Market in Iran: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 183: Iranian Melanoma Therapeutics Market Share Analysis
by Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 184: Israeli Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 185: Melanoma Therapeutics Market in Israel in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 186: Israeli Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 187: Israeli Melanoma Therapeutics Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 188: Melanoma Therapeutics Market in Israel in US$
Million by Therapy: A Historic Review for the Period 2009-2017
Table 189: Israeli Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 190: Saudi Arabian Melanoma Therapeutics Market Growth
Prospects in US$ Million by Type for the Period 2018-2025
Table 191: Melanoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Type: 2009-2017
Table 192: Saudi Arabian Melanoma Therapeutics Market by Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 193: Saudi Arabian Melanoma Therapeutics Market Growth
Prospects in US$ Million by Therapy for the Period 2018-2025
Table 194: Melanoma Therapeutics Historic Market Analysis in
Saudi Arabia in US$ Million by Therapy: 2009-2017
Table 195: Saudi Arabian Melanoma Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 196: Melanoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 197: United Arab Emirates Melanoma Therapeutics Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 198: Melanoma Therapeutics Market Share Distribution in
United Arab Emirates by Type: 2009 VS 2019 VS 2025
Table 199: Melanoma Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Therapy for the Period 2018-2025
Table 200: United Arab Emirates Melanoma Therapeutics Historic
Market Analysis in US$ Million by Therapy: 2009-2017
Table 201: Melanoma Therapeutics Market Share Distribution in
United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 202: Melanoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2018-2025
Table 203: Rest of Middle East Melanoma Therapeutics Historic
Market Analysis in US$ Million by Type: 2009-2017
Table 204: Rest of Middle East Melanoma Therapeutics Market
Share Breakdown by Type: 2009 VS 2019 VS 2025
Table 205: Melanoma Therapeutics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Therapy for the Period 2018-2025
Table 206: Rest of Middle East Melanoma Therapeutics Historic
Market Analysis in US$ Million by Therapy: 2009-2017
Table 207: Rest of Middle East Melanoma Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 208: African Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 209: Melanoma Therapeutics Market in Africa by Type: A
Historic Review in US$ Million for 2009-2017
Table 210: African Melanoma Therapeutics Market Share Breakdown
by Type: 2009 VS 2019 VS 2025
Table 211: African Melanoma Therapeutics Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 212: Melanoma Therapeutics Market in Africa by Therapy: A
Historic Review in US$ Million for 2009-2017
Table 213: African Melanoma Therapeutics Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
EISAI CO.
F. HOFFMANN-LA ROCHE AG
IOVANCE BIOTHERAPEUTICS, INC.
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818007/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.